These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28720422)

  • 1. Drug targeting to myofibroblasts: Implications for fibrosis and cancer.
    Yazdani S; Bansal R; Prakash J
    Adv Drug Deliv Rev; 2017 Nov; 121():101-116. PubMed ID: 28720422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.
    Affo S; Yu LX; Schwabe RF
    Annu Rev Pathol; 2017 Jan; 12():153-186. PubMed ID: 27959632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma.
    Tschumperlin DJ; Lagares D
    Pharmacol Ther; 2020 Aug; 212():107575. PubMed ID: 32437826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myofibroblast, a key cell in normal and pathological tissue repair.
    Darby IA; Zakuan N; Billet F; Desmoulière A
    Cell Mol Life Sci; 2016 Mar; 73(6):1145-57. PubMed ID: 26681260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse origins of the myofibroblast—implications for kidney fibrosis.
    Falke LL; Gholizadeh S; Goldschmeding R; Kok RJ; Nguyen TQ
    Nat Rev Nephrol; 2015 Apr; 11(4):233-44. PubMed ID: 25584804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the epithelial cells in fibrosis: a new concept for an old disease.
    Moll S; Chaykovska L; Meier M; Budd DC; Formentini I; Pomposiello S; Prunotto M
    Drug Discov Today; 2013 Jun; 18(11-12):582-91. PubMed ID: 23348679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myofibroblasts and lung fibrosis induced by carbon nanotube exposure.
    Dong J; Ma Q
    Part Fibre Toxicol; 2016 Nov; 13(1):60. PubMed ID: 27814727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of myofibroblast differentiation: a review.
    Yang X; Chen B; Liu T; Chen X
    Eur J Pharmacol; 2014 Jul; 734():83-90. PubMed ID: 24742377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.
    Wallach-Dayan SB; Elkayam L; Golan-Gerstl R; Konikov J; Zisman P; Dayan MR; Arish N; Breuer R
    J Autoimmun; 2015 May; 59():67-76. PubMed ID: 25812467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
    Kramann R; DiRocco DP; Humphreys BD
    J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective delivery of IFN-γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis.
    Poosti F; Bansal R; Yazdani S; Prakash J; Post E; Klok P; van den Born J; de Borst MH; van Goor H; Poelstra K; Hillebrands JL
    FASEB J; 2015 Mar; 29(3):1029-42. PubMed ID: 25466892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation.
    Dong J; Ma Q
    Part Fibre Toxicol; 2017 Jun; 14(1):18. PubMed ID: 28595626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis.
    Sun YB; Qu X; Caruana G; Li J
    Differentiation; 2016 Sep; 92(3):102-107. PubMed ID: 27262400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Fibrotic Diseases: Current Challenges in Fibrosis Research.
    Rosenbloom J; Macarak E; Piera-Velazquez S; Jimenez SA
    Methods Mol Biol; 2017; 1627():1-23. PubMed ID: 28836191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thy-1 expression, a possible marker of early myofibroblast development, in renal tubulointerstitial fibrosis induced in rats by cisplatin.
    Yuasa T; Juniantito V; Ichikawa C; Yano R; Izawa T; Kuwamura M; Yamate J
    Exp Toxicol Pathol; 2013 Jul; 65(5):651-9. PubMed ID: 22884260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?
    Radisky DC; Kenny PA; Bissell MJ
    J Cell Biochem; 2007 Jul; 101(4):830-9. PubMed ID: 17211838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Klotho on fibrosis and cancer: A renal focus on mechanisms and therapeutic strategies.
    Mencke R; Olauson H; Hillebrands JL
    Adv Drug Deliv Rev; 2017 Nov; 121():85-100. PubMed ID: 28709936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering the landslide: The tumor-promotional effects of myofibroblasts.
    Mehner C; Radisky DC
    Exp Cell Res; 2013 Jul; 319(11):1657-62. PubMed ID: 23528452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-Review.
    Sandner P; Berger P; Zenzmaier C
    Gerontology; 2017; 63(3):216-227. PubMed ID: 27784018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review).
    Di Benedetto P; Ruscitti P; Liakouli V; Del Galdo F; Giacomelli R; Cipriani P
    Mol Med Rep; 2019 Aug; 20(2):1488-1498. PubMed ID: 31257535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.